These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

998 related articles for article (PubMed ID: 19582160)

  • 1. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
    Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
    PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Holm K; Hegardt C; Gunnarsson H; Fagerholm R; Strand C; Agnarsson BA; Kilpivaara O; Luts L; Heikkilä P; Aittomäki K; Blomqvist C; Loman N; Malmström P; Olsson H; Johannsson OT; Arason A; Nevanlinna H; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R42. PubMed ID: 20576095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
    Holm K; Staaf J; Lauss M; Aine M; Lindgren D; Bendahl PO; Vallon-Christersson J; Barkardottir RB; Höglund M; Borg Å; Jönsson G; Ringnér M
    Breast Cancer Res; 2016 Feb; 18(1):27. PubMed ID: 26923702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression patterns associated with p53 status in breast cancer.
    Troester MA; Herschkowitz JI; Oh DS; He X; Hoadley KA; Barbier CS; Perou CM
    BMC Cancer; 2006 Dec; 6():276. PubMed ID: 17150101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models.
    Bergamaschi A; Hjortland GO; Triulzi T; Sørlie T; Johnsen H; Ree AH; Russnes HG; Tronnes S; Maelandsmo GM; Fodstad O; Borresen-Dale AL; Engebraaten O
    Mol Oncol; 2009 Dec; 3(5-6):469-82. PubMed ID: 19713161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs.
    Riaz M; van Jaarsveld MT; Hollestelle A; Prager-van der Smissen WJ; Heine AA; Boersma AW; Liu J; Helmijr J; Ozturk B; Smid M; Wiemer EA; Foekens JA; Martens JW
    Breast Cancer Res; 2013 Apr; 15(2):R33. PubMed ID: 23601657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
    Cornen S; Guille A; Adélaïde J; Addou-Klouche L; Finetti P; Saade MR; Manai M; Carbuccia N; Bekhouche I; Letessier A; Raynaud S; Charafe-Jauffret E; Jacquemier J; Spicuglia S; de The H; Viens P; Bertucci F; Birnbaum D; Chaffanet M
    PLoS One; 2014; 9(1):e81843. PubMed ID: 24416132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
    Gonçalves A; Charafe-Jauffret E; Bertucci F; Audebert S; Toiron Y; Esterni B; Monville F; Tarpin C; Jacquemier J; Houvenaeghel G; Chabannon C; Extra JM; Viens P; Borg JP; Birnbaum D
    Mol Cell Proteomics; 2008 Aug; 7(8):1420-33. PubMed ID: 18426791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
    Creighton CJ; Fu X; Hennessy BT; Casa AJ; Zhang Y; Gonzalez-Angulo AM; Lluch A; Gray JW; Brown PH; Hilsenbeck SG; Osborne CK; Mills GB; Lee AV; Schiff R
    Breast Cancer Res; 2010; 12(3):R40. PubMed ID: 20569503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability to generate senescent progeny as a mechanism underlying breast cancer cell heterogeneity.
    Mumcuoglu M; Bagislar S; Yuzugullu H; Alotaibi H; Senturk S; Telkoparan P; Gur-Dedeoglu B; Cingoz B; Bozkurt B; Tazebay UH; Yulug IG; Akcali KC; Ozturk M
    PLoS One; 2010 Jun; 5(6):e11288. PubMed ID: 20585577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
    Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
    Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
    Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridization.
    Jönsson G; Staaf J; Olsson E; Heidenblad M; Vallon-Christersson J; Osoegawa K; de Jong P; Oredsson S; Ringnér M; Höglund M; Borg A
    Genes Chromosomes Cancer; 2007 Jun; 46(6):543-58. PubMed ID: 17334996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns.
    Holm K; Hegardt C; Staaf J; Vallon-Christersson J; Jönsson G; Olsson H; Borg A; Ringnér M
    Breast Cancer Res; 2010; 12(3):R36. PubMed ID: 20565864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
    Sabatier R; Finetti P; Guille A; Adelaide J; Chaffanet M; Viens P; Birnbaum D; Bertucci F
    Mol Cancer; 2014 Oct; 13():228. PubMed ID: 25277734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape of somatic allelic imbalances and copy number alterations in HER2-amplified breast cancer.
    Staaf J; Jönsson G; Ringnér M; Baldetorp B; Borg A
    Breast Cancer Res; 2011; 13(6):R129. PubMed ID: 22169037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling of breast cell lines identifies potential new basal markers.
    Charafe-Jauffret E; Ginestier C; Monville F; Finetti P; Adélaïde J; Cervera N; Fekairi S; Xerri L; Jacquemier J; Birnbaum D; Bertucci F
    Oncogene; 2006 Apr; 25(15):2273-84. PubMed ID: 16288205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
    Bergamaschi A; Kim YH; Wang P; Sørlie T; Hernandez-Boussard T; Lonning PE; Tibshirani R; Børresen-Dale AL; Pollack JR
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1033-40. PubMed ID: 16897746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.